ArticleEJNMMI research2026

GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer.

Tokiyoshi Tanegashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.